FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Helix 51 Company
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has…
News Archive
Now Viewing
All News
Rosalind Franklin University College of Nursing Programs Awarded National Accreditation
Two Rosalind Franklin University nursing programs have earned full accreditation by the Commission…
Dr. Erin Howe Awarded Research Grant to Study Molecular Mechanisms Driving Metastatic Breast Cancer
Rosalind Franklin University cancer biologist Erin Howe, PhD, has been awarded a $100,000 grant…
PT Solutions and Rosalind Franklin University Partner to Address Physical Therapy Workforce Shortage and Access to Healthcare Education
A new partnership between Rosalind Franklin University (69ɫƬ) and PT Solutions Physical Therapy (PTS)…
NIH Fast-Track Grant for Novel Therapeutic to Treat Glioblastoma Awarded to Rosalind Franklin University Helix 51 Incubator Company
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has…
NIH Awards $9.8 million in Funding to Rosalind Franklin University Researchers for Projects Related to Brain Function and Diseases, Cancer and Parasitic Infections
Three Rosalind Franklin University scientists have been awarded approximately $9.8 million in funding…
New Directions: Center for Genetic Diseases
The new director of the Center for Genetic Diseases, molecular biologist Weihang “Valerie” Chai, PhD, wants to establish…
Grainger Support Primes Startups for Success
From nurturing companies in a world-class research environment to providing hands-on experiences for students, the Helix…
Reflecting on a Legacy of Discovery
Rosalind Franklin University of Medicine and Science became the first medical institution in the United States to recognize…
Transforming Clinical Practice
The AI-powered future is here, and it’s transforming the work of healthcare delivery, education and training. 69ɫƬ…